Doxorubicin(Adriamycin) hydrochloride
| Catalogue No. : |
C13593 |
| Product Name: |
Doxorubicin(Adriamycin) hydrochloride |
| Synonym: |
Adriamycin Hydrochloride;NSC 123127;DOX, Hydroxydaunorubicin hydrochloride;Doxorubicin HCL;NSC-123,127;NSC-123127 |
| Chemical Name: |
10-[(3-Amino-2,3,6-trideoxy-α-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride |
| CAS No. : |
25316-40-9 |
| Structure : |
|
| Molecular Formula: |
C27H29NO11.HCl |
| Molecular Weight: |
579.99 |
| Appearance: |
Orange red powder |
| Purity: |
>99% |
| Usage: |
Antitumor antibiotic agent that inhibits DNA topoisomerase II. DNA intercalator that inhibits nucleic acid synthesis and induces apoptosis. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
